Schedule 13G ownership disclosure

BRAINSTORM CELL THERAPEUTICS

Security class unavailable · CUSIP: 10501E201

Event date: 2022-02-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,425,853
Percent of class
6.6900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-022691
Form type
SC 13G
Filer
Abbhi Investments, LLC
CIK
CIK 1806888
Filed
Feb 14, 2022
Reporting period
Feb 14, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub